Disease: Acute myelocytic leukemia
- A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia
- A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm with Orbital Tumor as the Initial Symptom
- A comparative analysis of the clinical and genetic profiles of blast phase BCR::ABL1-negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia-related
- A novel immunogenic cell death-related classification indicates the immune landscape and predicts clinical outcome and treatment response in acute myeloid leukemia
- Advancements and Challenges in the Treatment of AML
- Advances in decision support for diagnosis and early management of acute leukaemia
- Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion
- Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis
- Association of Leukemia With ABO Blood Group Distribution and Discrepancy: A Review Article
- Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia
- Batimastat Induces Cytotoxic and Cytostatic Effects in In Vitro Models of Hematological Tumors
- Bone marrow-restricted aberrant myeloperoxidase expression in B-acute lymphoblastic leukemia: A diagnostic dilemma and mimicry of mixed phenotype acute leukemia
- Bortezomib suppresses acute myelogenous leukaemia stem-like KG-1a cells via NF-kappaB inhibition and the induction of oxidative stress
- CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment
- Characterization of relapse-supportive monocytic cells in acute myeloid leukemia
- Chemical Modifications to Enhance the Drug Properties of a VIP Receptor Antagonist (ANT) Peptide
- Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial
- Chronic myeloproliferative neoplasm in adulthood in CBL syndrome harboring a splice-site <em>CBL</em> variant alongside a novel constitutional <em>CSF3R</em> variant
- Clinical Analysis of Mitoxantrone Liposome in the Treatment of Children with High-Risk Acute Myeloid Leukemia
- Clinical Characteristics of CD4<sup>-</sup>CD56<sup>+</sup> Blastic Plasmacytoid Dendritic Cell Neoplasm
- Clinical outcomes and treatment patterns in adults with FLT3-ITD(mut+) acute myeloid leukemia undergoing allogeneic hemopoietic cell transplantation in the US and Canada
- Clonal Relapse Dynamics in Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation
- Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment
- Convergent epigenetic evolution drives relapse in acute myeloid leukemia
- Correlation of miR-155 Expression with Drug Sensitivity of FLT3-ITD(+) Acute Myeloid Leukemia Cell Line and Its Mechanism
- Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3-mutant acute myeloid leukemia
- Curcumin Combined with Thalidomide Inhibits Proliferation of KG-1 Cells and Its Related Mechanisms
- Current knowledge about FLT3 gene mutations, exploring the isoforms, and protein importance in AML
- Diagnostic utility of immunohistochemistry in detection of NPM1 mutations in acute myeloid leukemia with a patchy distribution
- Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid Leukemia and Overcoming Resistance of FLT3 Inhibitors
- Discovery of Highly Potent and Efficient CBP/p300 Degraders with Strong <em>In Vivo</em> Antitumor Activity
- Donor <em>KIR</em> genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight
- Duocarmycin SA Reduces Proliferation and Increases Apoptosis in Acute Myeloid Leukemia Cells In Vitro
- Early transfusion patterns improve the Molecular International Prognostic Scoring System (IPSS-M) prediction in myelodysplastic syndromes
- Effect of Shikonin on Autophagy and Apoptosis of Human Promyelocytic Leukemia Cells
- Effects of BMAL2 on Aerobic Glycolysis and Cell Proliferation in Acute Myeloid Leukemia Cells
- Elesclomol-Cu Induces Cuproptosis in Human Acute Myeloid Leukemia Cells
- Evaluating targeted therapies in older patients with <em>TP53</em>-mutated AML
- Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France
- Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study
- FLT3 agonists and secondary hematopoietic malignancies: a potential class effect
- FLT3 and IRAK4 Inhibitor Emavusertib in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia
- Fragment-based discovery of new potential DNMT1 inhibitors integrating multiple pharmacophore modeling, 3D-QSAR, virtual screening, molecular docking, ADME, and molecular dynamics simulation approaches
- From code to care: Clinician and researcher perspectives on an optimal therapeutic web portal for acute myeloid leukemia
- Genetic prediction of causal association between serum bilirubin and hematologic malignancies: a two-sample Mendelian randomized and bioinformatics study
- Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia
- Graft-versus-host disease after autologous stem cell transplantation in a recipient who underwent allogeneic stem cell transplantation 20 years earlier
- High throughput screening aids clinical decision-making in refractory acute myeloid leukaemia
- How lipid coating soothes the gut in AML therapy
- Identification of hub genes and potential molecular mechanisms related to drug sensitivity in acute myeloid leukemia based on machine learning
- Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients
- IFN-γ and CD38 in AML: a T-cell engagement made in heaven?
- Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody
- Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia
- Investigating the safety and feasibility of osteopathic manipulative medicine in hospitalized children and adolescent young adults with cancer
- KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia
- Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable <em>In Vivo</em> Studies: Discovery of TDI-11055
- Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients
- Multi-omics data integration and drug screening of AML cancer using generative adversarial network
- Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape
- PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells
- Polyphyllin I induces rapid ferroptosis in acute myeloid leukemia through simultaneous targeting PI3K/SREBP-1/SCD1 axis and triggering of lipid peroxidation
- Poor prognosis of SRSF2 gene mutations in patients treated with VEN-AZA for newly diagnosed acute myeloid leukemia
- Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies
- Post-stem cell transplant maintenance in FLT3(mut) acute myeloid leukemia - A retrospective analysis: Outcomes are improved with midostaurin but not with gilteritinib
- Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics
- Precision off-the-shelf natural killer cell therapies for oncology with logic-gated gene circuits
- Pro-Inflammatory Activation Suppresses TRAIL-induced Apoptosis of Acute Myeloid Leukemia Cells
- Prognostic Value of IGF2BP3 Gene Expression Levels in Patients with Acute Myeloid Leukemia
- Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers
- Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia
- Research Progress of Isocitrate Dehydrogenase Mutation-Positive Acute Myeloid Leukemia --Review
- Research Progress on the Prognostic Evaluation of MRD in Acute Myeloid Leukemia --Review
- Revisiting the role of measurable residual disease in FLT3 mutated acute myelogenous leukemia
- RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells
- RNF138 inhibits transcription factor C/EBPα protein turnover leading to differentiation arrest in AML
- RUNX1::RUNX1T1 Acute Myeloid Leukemia Cytogenetically Showing t(6;8)(p23;q22)
- Self-Stimulated Photodynamic Nanoreactor in Combination with CXCR4 Antagonists for Antileukemia Therapy
- Single-cell transcriptomics dissects the transcriptome alterations of hematopoietic stem cells in myelodysplastic neoplasms
- SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma
- Survival and Prognosis of Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes Transformed from Myelodysplastic Syndrome
- Survival for the fittest: guadecitabine in rel/ref AML
- Surviving the Storm: Cardiac Tamponade and Effusive Constrictive Pericarditis Complicated by Pericardial Decompression Syndrome Induced by COVID-19 Infection in the Setting of Newly Diagnosed Acute Myeloid Leukemia (AML)
- T cells take aim in AML: targeting IDH2
- T-Cell Engagers-The Structure and Functional Principle and Application in Hematological Malignancies
- Targeted delivery of HSP90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer
- The Efficacy and Safety of Venetoclax Combined with Azacitidine in the Treatment of Adult Patients with Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy
- The Expression of METTL14 in Patients with Newly Diagnosed Acute Myeloid Leukemia and Its Clinical Significance
- The Regulatory Effect of RNA m<sup>6</sup> A Methylation Modification on <em>KDM4B</em> Gene Expression in t (8;21) AML Cells by MeRIP-qPCR
- The Role of NK Cells in Allogeneic Hematopoietic Stem Cell Micro-Transplantation for Acute Myeloid leukemia
- The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1alpha and compromises development and progression of acute myeloid leukemia
- Therapy-related myeloid neoplasms after treatment for ovarian cancer: A retrospective single-center case series
- Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens
- Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression
- Tyrosine phosphorylation of CARM1 promotes its enzymatic activity and alters its target specificity
- UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation
- Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients
- Validation of mutated CEBPA bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry
- Venetoclax-Related Neutropenia in Leukemic Patients: A Comprehensive Review of the Underlying Causes, Risk Factors, and Management
- Venous thromboembolism in patients with acute myeloid leukemia: development of a predictive model